Researchers at Stanford Medicine have identified six distinct biotypes of depression and anxiety.

The study was published in Nature Medicine and utilized advanced brain imaging and machine learning techniques.

This precision psychiatry approach aims to match patients with the most effective therapies from the start, moving away from the trial-and-error method.

Distinct biotypes of depression and anxiety respond differently to treatments such as antidepressants or behavioral therapy.

The personalized approach aims to enhance treatment effectiveness and reduce the burden of treatment-resistant depression.

The findings introduce a new era of precision psychiatry, where brain imaging informs treatment decisions to improve outcomes for individuals with depression and anxiety.